166 research outputs found
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis.
Barretts esophagus (BE) involves a metaplastic replacement of native esophageal squamous epithelium (Sq) by columnar-intestinalized mucosa, and it is the main risk factor for Barrett-related adenocarcinoma (BAc). Ultra-conserved regions (UCRs) are a class non-coding sequences that are conserved in humans, mice and rats. More than 90% of UCRs are transcribed (T-UCRs) in normal tissues, and are altered at transcriptional level in tumorigenesis. To identify the T-UCR profiles that are dysregulated in Barretts mucosa transformation, microarray analysis was performed on a discovery set of 51 macro-dissected samples obtained from 14 long-segment BE patients. Results were validated in an independent series of esophageal biopsy/surgery specimens and in two murine models of Barretts esophagus (i.e. esophagogastric-duodenal anastomosis). Progression from normal to BE to adenocarcinoma was each associated with specific and mutually exclusive T-UCR signatures that included up-regulation of uc.58-, uc.202-, uc.207-, and uc.223- and down-regulation of uc.214+. A 9 T-UCR signature characterized BE versus Sq (with the down-regulation of uc.161-, uc.165-, and uc.327-, and the up-regulation of uc.153-, uc.158-, uc.206-, uc.274-, uc.472-, and uc.473-). Analogous BE-specific T-UCR profiles were shared by human and murine lesions. This study is the first demonstration of a role for T-UCRs in the transformation of Barretts mucosa
the isolpharm project a new isol production method of high specific activity beta emitting radionuclides as radiopharmaceutical precursors
The ISOLPHARM project explores the feasibility of exploiting an innovative technology to produce extremely high specific activity beta-emitting radionuclides as radiopharmaceutical precursors. This technique is expected to produce radiopharmaceuticals that are virtually mainly impossible to obtain in standard production facilities, at lower cost and with less environmental impact than traditional techniques. The groundbreaking ISOLPHARM method investigated in this project has been granted an international patent (INFN). As a component of the SPES (Selective Production of Exotic Species) project at the Istituto Nazionale di Fisica Nucleare–Laboratori Nazionali di Legnaro (INFN–LNL), a new facility will produce radioactive ion beams of neutron-rich nuclei with high purity and a mass range of 80–160 amu. The radioactive isotopes will result from nuclear reactions induced by accelerating 40 MeV protons in a cyclotron to collide on a target of UC[Formula: see text]. The uranium in the target material will be [Formula: see text]U, yielding radioactive isotopes that belong to elements with an atomic number between 28 and 57. Isotope separation on line (ISOL) is adopted in the ISOLPHARM project to obtain pure isobaric beams for radiopharmaceutical applications, with no isotopic contaminations in the beam or subsequent trapping substrate. Isobaric contaminations may potentially affect radiochemical and radionuclide purity, but proper methods to separate chemically different elements can be developed
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies
Minutes to hours after a nuclear event: available radiation poisoning antidotes and practical considerations on possible urgent approaches
Analisi farmaco-epidemiologica e valutazione farmacoeconomica sulla prescrizione di gonadotropine nella PMA e nel trattamento dell\u2019infertilit\ue0
Progetto Isolpharm_Ag: produzione di 111Ag e progettazione di radiofarmaci a scopo terapeutico
Deep learning for detection and segmentation of artefact and disease instances in gastrointestinal endoscopy
The Endoscopy Computer Vision Challenge (EndoCV) is a crowd-sourcing initiative to address eminent problems in developing
reliable computer aided detection and diagnosis endoscopy systems and suggest a pathway for clinical translation
of technologies. Whilst endoscopy is a widely used diagnostic and treatment tool for hollow-organs, there are several core
challenges often faced by endoscopists, mainly: 1) presence of multi-class artefacts that hinder their visual interpretation, and
2) difficulty in identifying subtle precancerous precursors and cancer abnormalities. Artefacts often affect the robustness of
deep learning methods applied to the gastrointestinal tract organs as they can be confused with tissue of interest. EndoCV2020
challenges are designed to address research questions in these remits. In this paper, we present a summary of methods
developed by the top 17 teams and provide an objective comparison of state-of-the-art methods and methods designed by
the participants for two sub-challenges: i) artefact detection and segmentation (EAD2020), and ii) disease detection and
segmentation (EDD2020). Multi-center, multi-organ, multi-class, and multi-modal clinical endoscopy datasets were compiled
for both EAD2020 and EDD2020 sub-challenges. The out-of-sample generalization ability of detection algorithms was also
evaluated. Whilst most teams focused on accuracy improvements, only a few methods hold credibility for clinical usability. The
best performing teams provided solutions to tackle class imbalance, and variabilities in size, origin, modality and occurrences
by exploring data augmentation, data fusion, and optimal class thresholding techniques
- …